Overview
Joan Schiller is a Hematologist Oncology provider in Dallas, Texas. Dr. Schiller has been practicing medicine for over 42 years and is rated as an Advanced provider by MediFind in the treatment of EGFR Positive Lung Cancer. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).
Her clinical research consists of co-authoring 90 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article and participated in 1 clinical trial in the study of EGFR Positive Lung Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
University Of Texas Southwestern Medical Center At Dallas
Jonathan Dowell is a Hematologist Oncology specialist and a Hematologist in Dallas, Texas. Dr. Dowell is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, and EGFR Positive Lung Cancer.
John Minna is an Oncologist and a Hematologist Oncology provider in Dallas, Texas. Dr. Minna is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC).
University Of Texas Southwestern Medical Center At Dallas
Jiu Kim is a Hematologist Oncology specialist and an Oncologist in Dallas, Texas. Dr. Kim is rated as an Advanced provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Pleuropulmonary Blastoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung AdenocarcinomaDr. Schiller isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Schiller isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Schiller isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- EGFR Positive Lung CancerDr. Schiller isAdvanced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Schiller isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Pleuropulmonary BlastomaDr. Schiller isAdvanced. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Schiller isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Schiller isAdvanced. Learn about Squamous Cell Lung Carcinoma.
- Experienced
- Breast CancerDr. Schiller isExperienced. Learn about Breast Cancer.
- Febrile NeutropeniaDr. Schiller isExperienced. Learn about Febrile Neutropenia.
- Ovarian CancerDr. Schiller isExperienced. Learn about Ovarian Cancer.
- Thymic Epithelial TumorDr. Schiller isExperienced. Learn about Thymic Epithelial Tumor.